KRAS is the most frequently mutated RAS gene; KRAS mutations occur in 32–35% of lung adenocarcinomas (LUAD), 41–50% of colorectal adenocarcinomas (COAD), and 86–88% of pancreatic adenocarcinomas (PAAD) [3,8]. This evidence concerns the gene KRAS and pancreatic adenocarcinoma.